Humira Biosimilar Drumbeats: Biocon Claims Edge For Adalimumab In US

 
• By Anju Ghangurde
  
Biocon Well Placed To Debut Humira Biosimilar In The US • Source: Shutterstock

More from Business

More from Scrip